OAC
OMERS Administration Corp’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.93M | Buy |
55,227
+500
| +0.9% | +$53.7K | 0.05% | 146 |
|
|
2025
Q1 | $5.52M | Sell |
54,727
-6,569
| -11% | -$663K | 0.05% | 147 |
|
|
2024
Q4 | $5.47M | Buy |
61,296
+10,431
| +21% | +$932K | 0.05% | 150 |
|
|
2024
Q3 | $4.26M | Sell |
50,865
-32,800
| -39% | -$2.75M | 0.04% | 184 |
|
|
2024
Q2 | $6.44M | Buy |
+83,665
| New | +$6.44M | 0.06% | 138 |
|
|
2023
Q2 | – | Sell |
-4,111,160
| Closed | -$206M | – | 242 |
|
|
2023
Q1 | $206M | Hold |
4,111,160
| – | – | 3.17% | 7 |
|
|
2022
Q4 | $190M | Hold |
4,111,160
| – | – | 3.05% | 5 |
|
|
2022
Q3 | $159M | Buy |
4,111,160
+1,624,700
| +65% | +$62.9M | 2.66% | 9 |
|
|
2022
Q2 | $92.7M | Sell |
2,486,460
-1,000,700
| -29% | -$37.3M | 1.34% | 35 |
|
|
2022
Q1 | $154M | Hold |
3,487,160
| – | – | 1.98% | 19 |
|
|
2021
Q4 | $148M | Buy |
3,487,160
+824,549
| +31% | +$35M | 1.92% | 17 |
|
|
2021
Q3 | $116M | Buy |
+2,662,611
| New | +$116M | 1.68% | 23 |
|
|
2021
Q2 | – | Sell |
-2,610,277
| Closed | -$101M | – | 28 |
|
|
2021
Q1 | $101M | Sell |
2,610,277
-498,362
| -16% | -$19.3M | 1.6% | 20 |
|
|
2020
Q4 | $112M | Buy |
3,108,639
+1,369,774
| +79% | +$49.2M | 2.02% | 15 |
|
|
2020
Q3 | $66.4M | Buy |
1,738,865
+98,251
| +6% | +$3.75M | 1.4% | 21 |
|
|
2020
Q2 | $57.6M | Buy |
+1,640,614
| New | +$57.6M | 1.91% | 13 |
|
|
2014
Q4 | – | Sell |
-237,300
| Closed | -$2.8M | – | 401 |
|
|
2014
Q3 | $2.8M | Sell |
237,300
-9,700
| -4% | -$115K | 0.08% | 143 |
|
|
2014
Q2 | $3.15M | Hold |
247,000
| – | – | 0.1% | 126 |
|
|
2014
Q1 | $3.34M | Hold |
247,000
| – | – | 0.11% | 112 |
|
|
2013
Q4 | $2.97M | Sell |
247,000
-223,400
| -47% | -$2.69M | 0.11% | 97 |
|
|
2013
Q3 | $5.52M | Buy |
470,400
+187,400
| +66% | +$2.2M | 0.52% | 49 |
|
|
2013
Q2 | $2.62M | Buy |
+283,000
| New | +$2.62M | 0.24% | 78 |
|